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Does R&D have an impact on firm growth, profits, and value? To most observers, the 
obvious answer is yes. However, the recent report by Booz-Allen-Hamilton (BAH 2006) 
seems to conclude that the share of spending devoted to research has no relationship to the 
economic performance of an enterprise, and offers support to the view that it is possible to 
compete successfully in the modern economy without investing in R&D. This issue is an 
important one because the large corporations they considered are responsible for the vast 
majority of private R&D spending in developed economies, and are therefore important 
actors in achieving the Lisbon agenda. 
 
Challenged by the results and recommendations of the BAH report, in this paper we assess 
some of the pitfalls to be avoided in using accounting data to estimate corporate R&D returns 
and illustrate a proper use of such data. We first offer a critique of important aspects of the 
methodology and of some of the main conclusions in the BAH report. Using similar data and 
a comparable approach, we then present our own estimates of the impact of R&D on the 
growth, profitability, and market value of public corporations, and contrast our interpretations 
and conclusions with that of the report.  
 
Our critique takes three parts: first, the data normally available in the financial accounts of 
firms is not well-suited to assessing the returns to R&D. Such expenditure is an investment in 
the future, but is generally treated by accountants as immediately expensable. There are also a 
number of issues in the interpretation of results based on gross versus net profits and in the 
robustness of estimates to the presence of extreme outliers in the data. Second, we discuss the 
difficulties arising from the fact that the theory that posits a relationship between R&D 
investment and subsequent returns is difficult to test if all firms make the “correct” 
investment decisions in an expected value sense. In the absence of substantial out of 
equilibrium behavior, we do not expect supranormal or subnormal returns to R&D. Third and 
last, there are a number of statistical and interpretive problems in drawing conclusions from 
the results of regressing output indicators on R&D. Chief among these is the confusion of low 
explanatory power with lack of impact -- in the presence of highly variable outcomes, the two 
are not the same.  
 
We then turn to our own analysis. Using data on approximately 1500 large public firms in 
R&D-intensive sectors from a number of OECD countries, we outline the underlying model 
that is used to measure returns to these kinds of investment, touching briefly on the 
measurement of depreciation that is needed to go from gross to net. We show that there are 
indeed strong relationships between investment in R&D and the market value and subsequent 
growth of firms on average. The relationship between R&D and current profitability is more 
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variable, as one would expect given our earlier discussion of the pitfalls in using accounting 
data. Our results thus confirm the average productivity and economic profitability of R&D 
investment, in spite of their expected intrinsic uncertainty, both across firms and across time. 
 
The paper concludes with a review and best practice summary for the problem of evaluating 
R&D performance as well as the performance of other innovation investments using 
accounting data, which is often all that is available to analysts and policy makers.  
 
Introduction 
Does R&D have an impact on firm growth, profits, and value? Anyone reading the recent 
report by Booz-Allen-Hamilton (2006, the “BAH Report”) might conclude the contrary. This 
report seems to offer support to skeptics, those who believe that it is possible to compete 
successfully in the modern economy without investment in R&D and that the share of 
spending devoted to research has no relationship to the economic performance of an 
enterprise (or a country). 
 
But this conclusion would not be warranted by the vast bulk of evidence in the economic and 
business management literature. Although it is certainly true that firm success is highly 
unpredictable and depends on many factors other than R&D investment and patenting, it is 
nevertheless the case that there is a strong relationship between these activities and the 
growth and profitability of firms, and it is extremely misleading to argue that there is not.  
 
In this brief we offer a critique of the analysis in the BAH report, bringing the considerable 
body of evidence in the research literature to bear. We discuss the ways in which BAH use 
their evidence to draw misleading conclusions which they then translate into 
recommendations that if they were followed, would leave most firms worse off than they are 
now.  
 
Perceptive readers and analysts may ask why we focus on the BAH report, as they will see 
immediately the weakness in its recommendations and conclusions. Our motivation is that the 
report has had some impact in business and policy communities via its appearance in 
summarized form in newspapers, business magazines and on the WEB. While we have 
nothing against “a report having a big impact,” if it were evidence-based and did not 
oversimplify the issues, we are concerned about the wide and rapid dissemination of a 
message relayed and amplified by well-read newspapers, which ultimately turns out to be 
largely wrong and misleading. There is risk that many readers will be at a minimum confused 
and at worst will take away mostly what is written in bold or italics: “firms that spend less on 
R&D than their competitors have superior financial performance,”2 or “Innovation 
champions show a ratio of R&D expenditures to sales that is below the average,”3 or “All 
these companies spend less than their competitors on research and development, yet outpace 
their industries across a wide range of performance metrics.”4 
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We would caution such readers that the BAH report completely ignores the previous 
literature on the returns to R&D, what has been learned from this research, and what the 
results mean for a firm. If, as been shown long since by economic researchers, the uncertainty 
inherent in the processes of research and innovation imply an equivalent uncertainty in the 
profitability of these investment at the level of an individual firm, there is no doubt that such 
profitability – when it is measured at the aggregate level or for the whole society - has been 
shown to be as high or higher than the profitability of investment in the physical capital. 
Econometricians are the first to recognize the great difficulties of measuring the output of the 
R&D at the firm level and of the interpretation of the results – in particular, difficulties in 
related to the measurement of the prices in the case of the new products,5 or to the question of 
the lag between investment in R&D and its contribution to performance.  
 
Even if taken separately each study seems fragile, the fact that their results agree to a great 
extent makes the conclusions more convincing. Such an intellectual achievement, to which 
scholars like Griliches, Mansfield, and Scherer have contributed, cannot be simply discarded 
without more careful study than has been presented in this report. 
 
The BAH report uses simplistic tools, essentially "cross-sectional" correlations, lacking even 
controls for industrial sector and country to say nothing of other relevant variables such as 
firm size and physical capital. It resorts to ex-post endogenous grouping of bad-performing-
high R&D firms versus high-performing low R&D firms. It interprets a low correlation value 
as being economically and statistically insignificant, which is not always the case. In 
addition, analyzing only R&D firms is a potential source of selectivity bias, which is not even 
alluded to in the Report.6 What about those firms that do no R&D? Do they perform better or 
worse than the firms in the sample? In short, the analysis confuses a group of selected trees 
with both the forest as a whole (the overall positive impact of R&D) and with each individual 
tree (the huge heterogeneity, which is to be expected at the micro economic level). 
 
The report misinterprets even its own results. Assume that the sample consists of a number of 
firms, each of which is pursuing an optimal R&D investment strategy, but under considerable 
uncertainty about the market, the competition, and future prices. Entry into this activity is not 
restricted, so on average we would expect the risk-adjusted returns to R&D to be the same as 
the returns to any other investment activity. What are the implications of these assumptions? 
First, if R&D is expensed and is not fluctuating a great deal over time within firm, we would 
not expect to observe much of a correlation between profits and R&D, because on average 
the firms get what they pay for and do not earn supranormal returns to R&D.7 There will be 
winners and losers, but winning will not be especially related to the level of R&D spending. 
Note that this does not imply that firms should not spend on R&D, simply that if all firms 
pursue what appears to them to be a good policy, we would not expect to see a strong 
relationship.  
                                                
5
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A second conclusion from this argument is that we would expect profits gross of R&D to be 
correlated with R&D, but that is a simple accounting correlation. Finally, we do expect 
market capitalization to be related to the level of R&D spending, under the assumption that it 
creates an intangible asset that yields returns into the future. With these observations in mind, 
let us look at the performance screens used in the report.  
 
The report uses seven performance screens: sales growth, gross profit to sales ratio, gross 
profit growth, operating income to sales ratio, operating income growth, market cap, and 
shareholder returns. For subsequent analysis, it is important to understand exactly how these 
performance indicators are defined. Gross profit is sales less the cost of goods sold, and is 
therefore gross of R&D expenditure. As indicated above, this implies that there will be 
simple accounting correlation between the gross profit to sales ratio and the R&D to sales 
ratio. Operating income is net of R&D expenditure and we do not expect much if any 
correlation between R&D intensity and the income to sales ratio if the firms are behaving in a 
profit-maximizing way.  
 
The proper measure of market capitalization is the market value of all claims on the firm’s 
assets, which includes debt and any preferred or convertible stock. If the firm’s investments 
in R&D are creating any intangible assets, market value will be correlated with R&D, once 
we control for the book value of the tangible assets. Thus the correct analysis of the 
relationship between market cap and R&D looks at the relationship between the total market-
to-book ratio and a measure of R&D capital (as a proxy for knowledge-related intangibles) 
rather than focusing only on market capitalization.  
 
Finally, the usual efficient markets hypothesis tells us that there should be little relationship 
between (lagged) R&D ot R&D intensity and shareholder returns: if there were such a 
systematic relationship, then there is a clear profit opportunity because R&D intensity could 
be used as a trading rule. This has been known for some time (see Pakes 1984 and Griliches 
et al 1991). It does not mean that we will not experience periods or episodes where R&D 
sytematically leads to higher or lower returns, but it does mean that these periods will not be 
predictable on the basis of past information and therefore that we do not expect a systematic 
relationship over time.  
 
Using data on large publicly traded US firmst from Compustat, we looked at the relationship 
between these seven performance measures and lagged R&D intensity to examine the 
findings reported by BAH more carefully and systematically. The first thing to note is that 
large databases of firm accounting data frequently contain errors and other data problems that 
can lead to misleading conclusions if the data are not cleaned and if nonrobust estimation 
methods are used. It is usually not feasible to manually correct the numbers, because the 
typical database size is on the order of one million numbers. Therefore two approaches are 
commonly used: ordinary least squares regression with outliers removed from the data or 
median regression, which is robust to the presence of outliers in the dependent variable. We 
have used both in this study, after cleaning the data first for the most egregious outliers (stock 
returns greater than 10,000 per cent, and so forth). We refer the reader to the Appendix A for 
details and to Appendix B for a comparison of trimmed OLS estimation to LAD estimation 
using period 2000-2005 data. 
 
Table 1 shows the results of our estimation of the following simple model: 
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 it it t j ity rβ λ δ ε= + + +  (0.1) 
 
y is one of the seven performance measures, r is the R&D to sales ratio lagged two years 
earlier to avoid any simultaneity bias, the λs are time (year) means, and the δs are industry 
means (included in the second columns). That is, we control for the average performance in 
each year and two digit industry. We estimated the model for two time periods: the 4 years 
2002-2005 and the 4 years 1996-1999, to illustrate how things can change over time. Note 
that these two periods bracket a period in which the technology part of the stock market 
experienced a large rise and fall due to the dotcom boom and year 2000 investment.  
 
Our discussion above had two clear predictions of a relationship, which are confirmed by 
Table 1. First, the market to book ratio is highly related to R&D intensity, with a coefficient 
that implies that the market to book ratio (Tobin’s q) rises by anywhere from 0.1 to 0.2 for 
every one per cent rise in R&D intensity. Second, gross income to sales is correlated one for 
one with the R&D to sales ratio, as we would expect given that it is gross of R&D. Firms that 
do more R&D have higher gross income to pay for it – no surprise there.  
 
With the exception of sales growth, which is somewhat surprisingly robustly related to past 
R&D intensity, the remainder of the table is more equivocal, as predicted. Shareholder 
returns are clearly unrelated to lagged R&D in either period. Operating income is positively 
related to past R&D in the first period but not the second, whereas the growth in operating 
income is strongly related to past R&D in the second period and much more weakly in the 
first. Because there is no reason to expect stable relationships between R&D and these 
measures, these results are not as surprising as they appear to be. The most interesting result 
is the relationship between past R&D intensity and contemporary sales growth, which 
translates into 0.2 per cent more sales growth per annum from a one time increase of R&D 
intensity of one per cent two years prior.  
 
Table 2 looks at the same relationship in a slightly different way, to focus on more long term 
relationships. The results in this table are based on a single cross section of average 
performance over a four-year period (1996-1999 and 2002-2005)  as it relates to R&D 
performed two years prior to the beginning of the period (1994 and 2000). With one 
exception, the results are now somewhat clearer. Those for Tobin’s q, the gross margin, and 
sales growth are the same as in Table 1. None of the other income measures are significantly 
related to R&D, as expected. However, shareholder returns are now very positively related to 
R&D in 1994, and not at all to R&D in 2000. What this means is that firms with high R&D 
intensity relative to their two-digit industry in 1994 experienced substantial positive returns 
between 1996 and 1999, but that firms with high R&D intensity in 2000 experienced no 
higher returns than other firms in 2002-2005. A likely explanation of this finding lies in the 
growth and then bursting of the dotcom bubble, which did impact some firms in other sectors 
than software/web. It would be misleading without further evidence to draw strong 
conclusions from the finding, as transitory variations in returns to R&D over time are to be 




The BAH report mixes the incorrect conclusions obtained from an uninformed and simplistic 
analysis with some common sense advice (such as the French saying " il vaut mieux etre 
riche et bien portant que pauvre et malade" or if you prefer "riche et intelligent que ..." . In 
English, “It is better to be rich and healthy than poor and sick.”) We can give here two or 
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three examples out of the report; such as: it is better to be good (lucky) at doing R&D than 
bad (unlucky) at it; or ”innovation must be achieved by different departments and business 
units within the same organization working in parallel rather than in isolation…….it also 
means looking outside your organization to partners, suppliers and customers for new and 
innovative ideas.” (BAH 2006, p. 61) 
 
The report conveys the idea that you can "free ride" on R&D done by others, which even at 
the firm level and even in the short run is unrealistic, and more so at the industry and 
economy level and in the long run. Firms need to have R&D and innovative activities 
themselves in order to appropriate efficiently the benefits of other firms' R&D and/or public 
R&D; and in a world of strong intellectual property rights they also have to buy the 
knowledge from other firms' R&D or cooperate with them in their R&D activities. It cannot 
be expected that all R&D spillovers will come from public R&D activities only, freely and in 
a long sustained way, in all fields and in an increasingly competitive and globalised world 
economy.  
 
Another claim is that the lower R&D-to-sales ratio of larger companies relative to smaller is 
advantageous (BAH 2006, pp. 54-55). But this is comparing apples to oranges: smaller 
companies tend to be those specializing in the innovative end of the value chain (such as chip 
design in semiconductors) and will perforce have larger R&D input than large firms, which 
are often capital-intensive and specialize more in other activities that have scale economies. 
The question of the relationship of R&D, size, and returns may be of interest, but it cannot be 
asked in isolation without taking account of other aspects of the firms’s production function.  
 
It is also the case that more than ever, private and public research constitute the constraining 
“point de passage” for the resolution of the great systematic problems of our time: those of 
energy and environment in a growth economy; those which relate to the future management 
of our health systems; those which treat the development of less-developed countries and the 
response to future demographic shocks, etc. For this reason alone, it might be hoped that out 
of this report economic decision makers themselves and public opinion do not retain only 
such ultra-simplistic messages. That would be a shame in the context where it is ever more 
important that discussions about R&D and knowledge ought to consider the idea of social 
returns along side that of private returns. 
 





Tobin's q (market to book) 21.5 (1.7) 17.0 (1.3) 13.19 (.78) 9.32 (1.09)
Shareholder returns .04 (.15) .06 (.17) -.29 (.10) -.17(.11)
Gross margin percentage 1.82 (.08) 1.53 (.09) 1.45 (.05) 1.34 (.06)
Operating margin percentage .14 (.03) .14 (.03) -.09 (.02) -.06 (.03)
Gross margin growth .14 (.07) .16 (.08) .17 (.05) .19 (.06)
Operating margin growth .34 (.15) .37 (.16) 1.10 (.14) 1.05 (.14)
Sales growth .30 (.08) .21 (.08) .14 (.04) .16 (.04)
Year dummies yes yes yes yes
2-digit industry dummies (25) no yes no yes
Number of observations (firms)
Source: S&P Compustat annual industrial file, authors' computations.
Sample is manufacturing plus oil and gas, communications, wholesale trade, and business services (R&D-doing firms only)
R&D intensity = R&D to sales ratio, lagged two years
Gross margin = sales less cost of goods sold (gross of R&D)
Operating margin = operating income (net of R&D)
Percentages are relative to sales
Shareholder returns are holding period capital gains plus dividends per share
Tobin's q is the ratio of total market value to the book value of tangible assets
Impact of lagged R&D intensity on various performance measures 
(LAD estimates)
1994-1999 2000-2005
5684 (1421) 5800 (1450)
 
 





Tobin's q (market to book) 27.9 (3.0) 20.9 (3.5) 14.2 (1.8) 10.0 (1.9)
Shareholder returns 2.36 (.47) 2.04 (.64) .22 (.15) .27 (.16)
Gross margin percentage 1.57 (.18) 1.33 (.19) 1.36 (.18) 1.27 (.14)
Operating margin percentage .16 (.07) .08 (.09) -.08 (.04) -.03 (.05)
Gross margin growth .24 (.12) .19 (.18) .14 (.05) .18 (.07)
Operating margin growth .42 (.22) .35 (.18) .34 (.25) .41 (.27)
Sales growth .28 (.07) .23 (.08) .15 (.04) .17 (.04)
2-digit industry dummies (25) no yes no yes
Number of observations (firms)
Source: S&P Compustat annual industrial file, authors' computations.
Sample is manufacturing plus oil and gas, communications, wholesale trade, and business services (R&D-doing firms only)
R&D intensity = R&D to sales ratio in 1994 (first 2 columns) or 2000 (last 2 columns)
Gross margin = sales less cost of goods sold (gross of R&D)
Operating margin = operating income (net of R&D)
Percentages are relative to sales
Shareholder returns are holding period capital gains plus dividends per share
Tobin's q is the ratio of total market value to the book value of tangible assets
Impact of lagged R&D intensity on various performance measures 









Booz-Allen-Hamilton (2006). Smart Spenders: The Global Innovation 1000. Web page presenting the 
report: www.boozallen.com/capabilities/services_article/18054973 
Denrell 2005. Harvard Business Review. 
Griliches, Z., Hall, B.H., Pakes, A. 1991. R&D, Patents, and Market Value Revisited: Is There a 
Second (Technological Opportunity) Factor? Economics of Innovation and New Technology 
1, 183-202. 
Pakes, A. 1985. On Patents, R&D, and the Stock Market Rate of Return. Journal of Political 
Economy 93, 390-409. 
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Appendix A: Data and sample 
 
The sample of firms comes from the 2005 Standard and Poor Compustat Annual Industrial 
file. Domestic US R&D-peforming firms in SICs 13 (oil and gas), 20-39 (manufacturing), 48 
(communications), 50-51 (wholesale trade), and 73 (business services including software) 
were selected. These are the only SICs with significant amounts of R&D. The distribution of 
the firms across industry is shown in Table A1. Almost half of the firms are in machinery 
including computer equipment, electrical equipment, scientific instruments, communications, 
and software, which can be loosely termed the ICT sector. The reminder are spread 
throughout manufacturing, with fewer than 10 per cent outside manufacturing.  
 
As preliminary screening to remove clear outliers and observations with incorrectly entered 
data, the following tests were applied: 
 
• No missing values 
• More than 100 employees 
• R&D to sales less than 100 per cent 
• Gross income positive (i.e., sales greater than the cost of goods sold) 
• Operating income to sales greater than -100% 
• Growth rates for gross income, operating income, sales, and equity less than 10,000 
per cent in absolute value 
• Tobin’s q (market to book) less than 100 
• A full 6 years of data during the relevant period (1994-1999 or 2000-2005) 
 
The net result of these screens reduced the number of firms in 2005 from about 2400 to 1450; 
this is the sample whose sectoral distribution is shown in Table A1. All these data were used 
in the LAD (least absolute deviations) regression. Additional screens were applied to choose 
the OLS sample:  
 
• Growth rates rates for gross income, operating income, sales, and equity less than 150 
per cent in absolute value 
• Tobin’s q (market to book) less than 10 
 
Together, these screens reduced the sample form 1450 firms to 1402 firms in the 2000-2005 
sample. 
  September 2007 
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Table A1: SIC distribution 
 
SIC Industry name # firms Share
13 Oil and gas extraction 51 3.5%
20 Food and Kindred Products 52 3.6%
21 Tobacco Products 4 0.3%
22 Textile Mill Products 7 0.5%
23 Apparel & Other Finished Prods 26 1.8%
24 Lumber and Wood Prods, ex Furn 8 0.6%
25 Furniture and Fixtures 19 1.3%
26 Paper and Allied Products 31 2.1%
27 Printing,Publishing & Allied inds 34 2.3%
28 Chemicals & Allied Products 128 8.8%
29 Petroleum Refining & Related Inds 18 1.2%
30 Rubber & Misc Plastics Prods 25 1.7%
31 Leather and Leather Products 14 1.0%
32 Stone,Clay,Glass,Concrete Prods 18 1.2%
33 Primary Metal Industries 33 2.3%
34 Fabr Metal,ex Mach,Trans Eq 39 2.7%
35 Indl, Comml Mach,Computer Eq 145 10.0%
36 Electrical Eq, ex Computers 181 12.5%
37 Transportation Equipment 55 3.8%
38 Meas Inst; Photo Goods; Watches 146 10.1%
39 Misc Manufacturng Industries 26 1.8%
48 Communications 75 5.2%
50 Durable Goods - wholesale 51 3.5%
51 Nondurable Goods - wholesale 26 1.8%
73 Business services 238 16.4%
Total in 2005 1450
 
 




Tobin's q (market to book) 7.88 (.70) 5.23 (.74) 13.19 (.78) 9.32 (1.09)
Shareholder returns -.60 (.08) -.44 (.09) -.29 (.10) -.17(.11)
Gross margin percentage 1.31 (.07) 1.27 (.08) 1.45 (.05) 1.34 (.06)
Operating margin percentage -.35 (.07) -.26 (.09) -.09 (.02) -.06 (.03)
Gross margin growth -.06 (.06) -.00 (.07) .17 (.05) .19 (.06)
Operating margin growth .09 (.12) .13 (.14) 1.10 (.14) 1.05 (.14)
Sales growth -.04 (.05) .01 (.06) .14 (.04) .16 (.04)
Year dummies yes yes yes yes
2-digit industry dummies (25) no yes no yes
*OLS with all growth rate variables trimmed at 150%, q<10; 4728 observations on 1402 firms; clustered standard errors
**Median quantile regression; 5800 observations on 1450 firms; bootstrap standard errors
Source: S&P Compustat annual industrial file, authors' computations.
Sample is manufacturing plus oil and gas, communications, wholesale trade, and business services (R&D-doing firms only)
R&D intensity = R&D to sales ratio, lagged two years
Gross margin = sales less cost of goods sold (gross of R&D)
Operating margin = operating income (net of R&D)
Percentages are relative to sales
Shareholder returns are holding period capital gains plus dividends per share
Tobin's q is the ratio of total market value to the book value of tangible assets
OLS* LAD**







Tobin's q (market to book) 8.7 (1.2) 6.3 (1.1) 14.2 (1.8) 10.0 (1.9)
Shareholder returns .05 (.15) .11 (.17) .22 (.15) .27 (.16)
Gross margin percentage 1.15 (.13) 1.07 (.14) 1.36 (.18) 1.27 (.14)
Operating margin percentage -.17 (.09) -.08 (.09) -.08 (.04) -.03 (.05)
Gross margin growth .12 (.09) .22 (.09) .14 (.05) .18 (.07)
Operating margin growth .14 (.20) .23 (.22) .34 (.25) .41 (.27)
Sales growth .06 (.06) .12 (.07) .15 (.04) .17 (.04)
2-digit industry dummies (25) no yes no yes
*Ordinary least squares with all growth rate variables trimmed at 150%, q<10; 1203 firm observations
** Least absolute deviations (median) regression with 1454 firm observations; bootstrap standard errors
Source: S&P Compustat annual industrial file, authors' computations.
Sample is manufacturing plus oil and gas, communications, wholesale trade, and business services (R&D-doing firms only)
R&D intensity = R&D to sales ratio in the year 2000
Gross margin = sales less cost of goods sold (gross of R&D)
Operating margin = operating income (net of R&D)
Percentages are relative to sales
Shareholder returns are holding period capital gains plus dividends per share
Tobin's q is the ratio of total market value to the book value of tangible assets
Impact of lagged R&D intensity on various performance measures 
(LAD estimates using 4-year averages 2002-2005)
OLS* LAD**
Method of estimation
 
 
